Pujol H - Search Results

1

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer.

Pujol JL, Grenier J, Daurès JP, Daver A, Pujol H, Michel FB. Pujol JL, et al. Among authors: pujol h. Cancer Res. 1993 Jan 1;53(1):61-6. Cancer Res. 1993. PMID: 7677981

2

Immunohistochemical study of P-glycoprotein distribution in lung cancer.

Pujol JL, Simony J, Gautier V, Marty-Ané C, Pujol H, Michel FB. Pujol JL, et al. Among authors: pujol h. Lung Cancer. 1993 Oct;10(1-2):1-12. doi: 10.1016/0169-5002(93)90304-g. Lung Cancer. 1993. PMID: 7915180

3

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.

Pujol P, Maudelonde T, Daures JP, Rouanet P, Brouillet JP, Pujol H, Rochefort H. Pujol P, et al. Among authors: pujol h. Cancer. 1993 Mar 15;71(6):2006-12. doi: 10.1002/1097-0142(19930315)71:6<2006::aid-cncr2820710614>3.0.co;2-q. Cancer. 1993. PMID: 8443752

4

Cyfra 21-1, a new marker of lung cancer.

Grenier J, Pujol JL, Guilleux F, Daures JP, Pujol H, Michel FB. Grenier J, et al. Among authors: pujol h, pujol jl. Nucl Med Biol. 1994 Apr;21(3):471-6. doi: 10.1016/0969-8051(94)90070-1. Nucl Med Biol. 1994. PMID: 9296767 Clinical Trial.

5

In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.

Simony J, Pujol JL, Radal M, Ursule E, Michel FB, Pujol H. Simony J, et al. Among authors: pujol h, pujol jl. Cancer Res. 1990 Jul 15;50(14):4382-7. Cancer Res. 1990. PMID: 2163748

6

Phase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue.

Pujol H, Girault J, Rouanet P, Fournier S, Grenier J, Simony J, Fourtillan JB, Pujol JL. Pujol H, et al. Among authors: pujol jl. Cancer Chemother Pharmacol. 1995;36(6):493-8. doi: 10.1007/BF00685799. Cancer Chemother Pharmacol. 1995. PMID: 7554041 Clinical Trial.

7

Multivariate analysis of prognostic factors for curative resectable rectal cancer.

Domergue J, Rouanet P, Daures JP, Dubois JB, Joyeux H, Solassol C, Pujol H. Domergue J, et al. Among authors: pujol h. Eur J Surg Oncol. 1989 Apr;15(2):93-8. Eur J Surg Oncol. 1989. PMID: 2703066

8

Tumor progression and oxidant-antioxidant status.

Gerber M, Astre C, Ségala C, Saintot M, Scali J, Simony-Lafontaine J, Grenier J, Pujol H. Gerber M, et al. Among authors: pujol h. Cancer Lett. 1997 Mar 19;114(1-2):211-4. doi: 10.1016/s0304-3835(97)04665-x. Cancer Lett. 1997. PMID: 9103294

9

[Restraints of an organized mass screening of cancer of the breast].

Lamarque JL, Pujol H, Daures JP, Laurent JC, Cherif Cheikh J, Boulet P, Pujol J. Lamarque JL, et al. Among authors: pujol h, pujol j. Pathol Biol (Paris). 1992 Nov;39(9):845. Pathol Biol (Paris). 1992. PMID: 1538899 French. No abstract available.

10

The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial.

Romieu G, Maudelonde T, Ulmann A, Pujol H, Grenier J, Cavalie G, Khalaf S, Rochefort H. Romieu G, et al. Among authors: pujol h. Bull Cancer. 1987;74(4):455-61. Bull Cancer. 1987. PMID: 3311238 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters